Papers
4
Total Citations
184
H-Index
4
About
Daniele Robesti is a leading urological surgeon and researcher whose work centers on improving surgical precision and outcomes in prostate cancer. His primary research focuses on the application of prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) to enhance the detection of lymph node metastases during robot-assisted radical prostatectomy. In his landmark prospective Phase 2 study, Robesti demonstrated that PSMA-RGS can identify lymph node invasion with high accuracy, potentially reducing the need for extended pelvic lymph node dissection and its associated morbidity. This work, cited over 94 times, has been instrumental in advancing the field of targeted surgical guidance. He has also contributed to standardizing complication reporting in urologic surgery, with his 2018 paper on implementing EAU guidelines receiving 72 citations. More recently, Robesti has explored multimodal treatment strategies for oligometastatic prostate cancer, combining surgery with metastasis-directed therapy. His ongoing efforts to define optimal target-to-background ratios for PSMA-RGS continue to refine this innovative technique, positioning him as a key figure in the evolution of precision surgery for prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4